Thabiso Mutirwara mutirwarat@dailynews.co.zw A CLINICAL trial for a ground-breaking HIV vaccine has been launched in the country. The novel vaccine candidate will evaluate immune responses to highly networked HIV T-cell epitopes. The trial is a result of close collaboration among the Africa Clinical Research Network, the Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of…

The vaccine candidate, Gorilla Adenovirus Vectored HIV Networked Epitopes Vaccine (GRAdHIVNE1), was first administered on July 28, 2025.
